# FDA Inspection 1251315 - Leading Pharma, LLC - October 21, 2024

Source: https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/93fdc81c-a4f9-4b4b-b685-064a805089a3
Source feed: FDA_Inspections

> FDA Inspection 1251315 for Leading Pharma, LLC on October 21, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251315
- Company Name: Leading Pharma, LLC
- Inspection Date: 2024-10-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1129205 - 2020-08-11](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/0574a1a2-3e0f-419f-b564-b4a98975f9f0)
- [FDA Inspection 1079111 - 2019-01-31](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/43dce4fe-af89-41b7-a83e-fbbc3182626f)
- [FDA Inspection 1067964 - 2018-08-31](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/27259ff7-077f-4b61-b7d5-020cb1c26543)
- [FDA Inspection 1010916 - 2017-04-14](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/9497b89c-936a-498c-8041-02e339659bb2)
- [FDA Inspection 1010916 - 2017-04-14](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/4f896dde-05b0-49a4-9dd9-003b39456895)

Company: https://www.keypedia.com/companies/leading-pharma-llc/9cbe169a-2e1b-4cdb-848c-209798a79db0

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248